NAT8


Description

The NAT8 (N-acetyltransferase 8 (putative)) is a protein-coding gene located on chromosome 2.

N-acetyltransferase 8 is a protein encoded by the NAT8 gene in humans. Mutations in NAT8 have been linked to chronic kidney disease.

NAT8 catalyzes the acetylation of cysteine S-conjugates to form mercapturic acids, a crucial step in detoxification of reactive electrophiles. This process starts with glutathione S-conjugate formation and progresses through cysteine S-conjugate intermediates, ultimately leading to water-soluble mercapturic acids that are excreted in urine or bile. Additionally, NAT8 may exhibit lysine N-acetyltransferase activity, acetylating peptidyl-lysine residues in various proteins. This activity could regulate apoptosis by influencing PROM1 expression and acetylation. Furthermore, NAT8 might regulate amyloid beta-peptide secretion through acetylation and expression regulation of BACE1 in neurons.

NAT8 is also known as ATase2, CCNAT, CML1, GLA, Hcml1, TSC501, TSC510.

Associated Diseases



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.